Research goal
Skin
Peptides studied for collagen synthesis, dermal remodeling, wound healing acceleration, and barrier function — the evidence base behind research-grade skin peptides.
Skin Peptide Research
Skin aging is driven by a well-characterised decline in collagen production (approximately 1% per year after age 25), reduced fibroblast activity, accumulated oxidative damage, and impaired barrier function. Research-grade skin peptides target these mechanisms at the molecular level, making them subjects of active investigation in dermatology, wound care, and anti-aging science.
Key Research Areas
Collagen & ECM Remodeling
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is the most studied skin peptide, shown to upregulate collagen types I, III, and VI in fibroblast cultures at nanomolar concentrations. It simultaneously modulates matrix metalloproteinases (MMP-2/9) to clear damaged extracellular matrix while promoting new collagen deposition — a remodeling balance critical to skin rejuvenation research.
Wound Healing
GHK-Cu and BPC-157 both accelerate wound closure in preclinical models. GHK-Cu promotes angiogenesis via VEGF upregulation; BPC-157 promotes endothelial cell migration and tube formation (Sikiric et al., 2018, PMID: 29210636).
Antioxidant Defense
GHK-Cu induces superoxide dismutase-1 (SOD1) and catalase, reducing the oxidative burden on aged dermal cells. This antioxidant activity is documented in the comprehensive gene expression analysis by Pickart & Margolina (2018, PMID: 29987172).
Frequently Asked Questions
What peptides are best for skin anti-aging research? GHK-Cu (copper tripeptide-1) is the most evidence-backed peptide for skin aging research, with documented effects on collagen synthesis, gene expression, and wound healing. BPC-157 is also studied in skin wound models. Research on these compounds uses fibroblast cultures, ex vivo skin biopsies, and controlled animal models.
What does research show about copper peptides for anti-aging? Studies confirm GHK-Cu upregulates collagen I, III, and VI; suppresses inflammatory cytokines IL-6 and TNF-α; promotes angiogenesis; and modulates 4,082 human genes toward a more regenerative state. Plasma GHK-Cu concentrations decline ~60% between ages 20 and 60, correlating with reduced skin repair capacity (Pickart & Margolina, 2018).
Research Use Only · Not for human consumption.